Showing 5681-5690 of 5949 results for "".
- Suneva Selects Quinnova to Co-promote ReFissahttps://practicaldermatology.com/news/20130610-suneva_selects_quinnova_to_co-promote_refissa/2459520/Suneva Medical, Inc. selected Quinnova Pharmaceuticals, LLC to co-promote ReFissa. ReFissa is the only FDA approved 0.05% tretinoin emollient cream indicated for the treatment of fine wrinkles, mottled hyperpigmentation, and tactile roughness of facial skin.
- Jurlique Product Supports the Underservedhttps://practicaldermatology.com/news/20130607-jurlique_product_supports_the_underserved/2459521/The Jurlique Ideas of Beauty Fund by Jurlique and Chrysalis supports the empowerment of women to lead better lives. Through the fund, Jurlique donates to organizations around the world committed to helping women. Proceeds from every
- New Technical Manager at Jurliquehttps://practicaldermatology.com/news/20130531-new_technical_manager_at_jurlique/2459527/Jurlique appointed Connie Lim to Technical Manager of Global Product Development. In her new role, Ms. Lim will drive innovative formula development, provide technical support, and monitor performance and key milestones in global new product development efforts. Ms. Lim comes to Jurlique with mor
- Two Melanoma Drugs Win FDA Approvalhttps://practicaldermatology.com/news/20130530-two_melanoma_drugs_win_fda_approval/2459528/The FDA approved two new drugs for metastatic or inoperable melanoma, dabrafenib (Tafinlar) and trametinib (Mekinist). Dabrafenib is an inhibitor of the BRAF gene when it carries the so-called V600E mutation. Trametinib inhibits a target known as MEK and is effective primarily against melanomas carr
- Workshops Added to Aesthetic Extender Symposium 2013https://practicaldermatology.com/news/20130524-workshops_added_to_aesthetic_extender_symposium_2013/2459531/Five additional workshops will be held at the Aesthetic Extender Symposium (AES) at the Boca Raton Resort & Club from October 31 - November 3: Friday, November 1, 3:45 - 5:45 PM Innovations in Facial Aesthetic Medicine: Mastering the Art and Science of Injectables Michael Kane, MD & Jason Pozner,
- Skin Health Seminars to Begin Next Monthhttps://practicaldermatology.com/news/20130522-skin_health_seminars_to_begin_next_month/2459532/ZO Skin Health, Inc. will host a series of educational seminars and webinars on “Expanded Concepts and Principles of Skin Health Science,” created and presented by Zein Obagi, MD, and board-certified dermatologist Monika Kiripolsky, MD. Each seminar plans to educate skincare professionals and cons
- Clark Pharmaceuticals, Ferndale Healthcare Launch DerMendhttps://practicaldermatology.com/news/20130521-clark_pharmaceuticals_ferndale_healthcare_launch_dermend/2459534/Clark Pharmaceuticals partnered with Ferndale Healthcare to launch DerMend Moisturizing Bruise Formula. The formula is predicated on the idea that skin over 50 tends to get thinner and bruises more easily. Blood thinners, even those like low-dose baby aspirin, can cause skin to bruise. DerMend is de
- Anti-bacterial Soap Under FDA Reviewhttps://practicaldermatology.com/news/20130520-anti-bacterial_soap_under_fda_review/2459537/The Food and Drug Administration (FDA) is studying whether triclosan is safe and effective. The FDA's findings could have implications for a $1 billion industry that includes hundreds of anti-bacterial soaps and body washes, particularly in acne washes. The review comes amid recent studies that have
- Georgia Governor Signs AMA Model Legislationhttps://practicaldermatology.com/news/20130520-georgia_governor_signs_ama_model_legislation/2459538/Georgia lawmakers enacted legal protections for physicians engaged in quality and delivery improvement initiatives included in the federal health care reform law. This first-of-its-kind legislation reinforces the concept that medical decisions are made based on a patient's unique medical needs. The
- L'Oreal Paris Partners with Melanoma Research Alliancehttps://practicaldermatology.com/news/20130520-loreal_paris_partners_with_melanoma_research_alliance/2459539/L'Oreal Paris formed an alliance with the Melanoma Research Alliance (MRA). Over the next three years, L'Oreal Paris will donate over $750,000 to the MRA to fund the new L'Oreal Paris-MRA Team Science Award, led by internationally renowned cancer researcher Dr. Meenhard Herlyn, to research ways to h